USP1 Promotes GC Metastasis via Stabilizing ID2.

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Gastric cancer (GC) is a leading cause of cancer mortality worldwide.
• Recurrence and metastasis significantly contribute to the poor survival rates in advanced GC.
• USP1 overexpression is implicated in various cancers, suggesting a role in tumorigenesis.

Purpose of the Study:

• To investigate the precise role of USP1 in GC metastasis.
• To elucidate the underlying molecular mechanisms by which USP1 influences GC progression.
• To evaluate USP1 as a potential biomarker and therapeutic target for GC.

Main Methods:

• Analysis of USP1 expression in GC tissues and correlation with patient survival.
• In vitro and in vivo experiments using real-time cellular analysis (RTCA) to assess metastasis.
• Mechanistic studies to identify downstream targets and regulatory pathways of USP1.

Main Results:

• USP1 was found to be overexpressed in GC tissues, with higher levels correlating with poorer survival.
• Knockdown of USP1 significantly inhibited GC cell metastasis both in vitro and in vivo.
• USP1 was shown to promote GC metastasis by upregulating and stabilizing ID2 expression via deubiquitination.

Conclusions:

• USP1 plays a crucial role in promoting GC metastasis.
• USP1 stabilizes ID2 expression, driving GC progression.
• USP1 represents a potential diagnostic biomarker and therapeutic target for gastric cancer.